Allergy Treatment Market worth USD 29,194.7 million by 2030

The Market Statsville Group (MSG) publishes the new report on the "Allergy Treatment Market by Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies), by Treatment (Anti-allergy Drugs and Immunotherapy), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Retailers, and Others), by Dosage Form (Oral, Inhalers, Intranasal, and Others), by Region – Global Share and Forecast to 2030". The global allergy treatment market size is estimated to grow from USD 17,773.4 million in 2021to USD 29,194.7 million by 2030, at a CAGR of 6.4% during the forecast period. The rising cases of food allergies are expected to increase the demand for allergy treatment, thereby leading to the market's high growth over the forecast period. As per a 2021 United States Food and Drug Administration (USFDA) article, some major food allergens found are milk, egg, peanut, tree nuts, wheat, soy, fish, and crustacean shellfish, which are responsible for most of serious food allergy reactions, across the world. Therefore, the incidences of allergic diseases through food have increased dramatically over the past decade.

Moreover, With the increase in allergic reactions, there are rising investments seen worldwide for the development of novel treatments. This has increased the need for novel allergy therapies that are highly effective. As a result, many organizations and companies worldwide have increased in demand and are heavily investing in developing novel therapies. For instance, in 2020, Nestlé Health Sciences has invested around USD 200 million in Aimmune Therapeutics to expand its investment in allergy-drug specialists.

Global Allergy Treatment Market Segmentation

The overall allergy treatment market has been segmented into the type, treatment, distribution channels, dosage form, and region.

• By Type (Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, and Other Allergies)
• By Treatment (Anti-allergy Drugs and Immunotherapy)
• By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Retailers, and Others)
• By Dosage Form (Oral, Inhalers, Intranasal, and Others)
• By Region (US, Canada, Mexico, UK, Germany, France, Italy, Spain, China, Japan, India, South Korea, Southeast Asia, Australia, Saudi Arabia, UAE, South Africa, Qatar, Nigeria, Israel, Brazil, Argentina, Peru)

Anti-allergy Drugs, by treatment, hold the largest market share during the forecast period

The global allergy treatment market is segregated into anti-allergy drugs and immunotherapy based on treatment. The anti-allergy drugs segment generated the highest revenue of 84.2% of the global allergy treatment market in 2021, and it is expected to register a significant CAGR from 2022 to 2030. Further, anti-allergy drugs have been segmented into antihistamines, corticosteroids, decongestants, and other anti-allergy drugs. Antihistamines work by reducing or blocking histamine processes in an allergic reaction. Antihistamines come in different dosage forms such as pills, chewable tablets, capsules, liquids, eye drops, and sprays. There are also injectable forms used mainly in health care settings.

Moreover, corticosteroids have immunosuppressive, anti-inflammatory, and vasoconstrictive effects; the corticosteroids increase the synthesis of beta-adrenergic receptors in tissues, inhibit the formation of leukotrienes, and prevent migration of inflammatory cells to the site of allergic injury. Thus, they have large applications in allergic treatments like asthma, anaphylaxis, urticaria and angioedema, rhinitis, contact dermatitis, etc.

Don't miss out on business opportunities in Allergy Treatment Market. Speak to our research analyst and gain crucial market insights that will benefit your business grow.

North America accounts for the largest market share in the allergy treatment market in 2021

Based on the regions, the global allergy treatment market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, North America accounted for the highest market share of 41.3% in the global allergy treatment market and was anticipated to maintain its dominance throughout the forecast period. The allergy treatment market in the United States is anticipated to boost due to the rise in allergy incidence and technological advancements in allergy treatments. Allergy is a common health issue among the population of the United States. According to the 2021 survey of the Asthma and Allergy Foundation of America, almost 25 million people in the United States were diagnosed with asthma.

In Canada, the indicators for allergies are steadily rising, with the dominance of different types of allergies, such as food allergies, peanut allergies, and sesame allergies. According to a report published by Food Allergy Canada, in 2018, over 2.6 million Canadians, including almost 500,000 children, were suffering from food allergies daily. The Government of Canada focuses on providing Canadians with the information they require to make healthy and safe food choices. The CFIA (Canadian Food Inspection Agency) and Health Canada work jointly with provincial, municipal, and territorial partners and industries to achieve this goal.

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the allergy treatment market. It also consists of the profiles of leading companies such as ALK-Abello AS, AbbVie Inc. (Allergan), Bausch Health Companies Inc., Alembic Pharmaceuticals Limited, F. Hoffmann-La Roche Ltd, Nicox SA, GlaxoSmithKline PLC, Dermapharm Holding SE, Allergy Therapeutics PLC, Johnson & Johnson, Leti Pharma, Novartis International AG, Sanofi SA, Stallergenes Greer PLC, and Teva Pharmaceutical Industries.

Browse complete report: https://www.marketstatsville.com/allergy-treatment-market

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

416, East Standsberry Street, Perkins, Oklahoma 74059, USA

USA: +1-580-205-2707 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com